Showing results (51-60 of 190) with videos related to
Sort By:
Pageof 19
Experimental Eye Research|May 8, 2012
In vivo detection of experimental optic neuritis by pupillometryKenneth S Shindler, Karen Revere, Mahasweta Dutt, et al.Journal of the National Cancer Institute|September 11, 2008
Priorities for improving the management of gastroenteropancreatic neuroendocrine tumorsIrvin M Modlin, Steven F Moss, Daniel C Chung, et al.Cancer Research|March 5, 2004
Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancerYusuke Mizukami, Jingnan Li, Xiaobo Zhang, et al.Cancer Biology & Therapy|November 1, 2005
Wnt signaling can repress thrombospondin-1 expression in colonic tumorigenesisWon-Seok Jo, Yusuke Mizukami, Eva-Maria Duerr, et al.Surgery|August 20, 2010
Prophylactic total gastrectomy for individuals with germline CDH1 mutationPrakash K Pandalai, Greg Y Lauwers, Daniel C Chung, et al.Clinical Endocrinology|April 28, 2005
Mutational analysis of PPARG as a candidate tumour suppressor gene in enteropancreatic endocrine tumoursJessica Costa-Guda, Evan D Rosen, Robert T Jensen, et al.Journal of Genetic Counseling|November 11, 2023
Patient decisions regarding cancer gene panel testing: An exploratory studyMargaret M Emmet, Yuchiao Chang, Daniel C Chung, et al.Journal of General Internal Medicine|January 15, 2015
Predicting Non-Adherence with Outpatient Colonoscopy Using a Novel Electronic Tool that Measures Prior Non-AdherenceDaniel M Blumenthal, Gaurav Singal, Shikha S Mangla, et al.Nature Chemical Biology|October 26, 2023
A genetically encoded tool to increase cellular NADH/NAD<sup>+</sup> ratio in living cellsXingxiu Pan, Mina L Heacock, Evana N Abdulaziz, et al.The Journal of Clinical Endocrinology and Metabolism|August 6, 2002
Mutational analysis of Smad3, a candidate tumor suppressor implicated in TGF-beta and menin pathways, in parathyroid adenomas and enteropancreatic endocrine tumorsTrisha M Shattuck, Jessica Costa, Megan Bernstein, et al.Pageof 19